Antenatal therapy with sildenafil: don't throw the baby out with the bathwater
- 5 February 2019
- journal article
- letter
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 53 (2) , 274-275
Abstract
No abstract availableFunding Information
- KU Leuven (C32/17/054)
This publication has 7 references indexed in Scilit:
- Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety studyTrials, 2018
- Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER ConsortiumUltrasound in Obstetrics & Gynecology, 2018
- Sildenafil Citrate Therapy for OligohydramniosObstetrics & Gynecology, 2017
- Clinically relevant timing of antenatal sildenafil treatment reduces pulmonary vascular remodeling in congenital diaphragmatic herniaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2016
- Transplacental sildenafil rescues lung abnormalities in the rabbit model of diaphragmatic herniaThorax, 2016
- Reducing the risk of fetal distress with sildenafil study (RIDSTRESS): a double-blind randomised control trialJournal of Translational Medicine, 2016
- Antenatal Sildenafil Treatment Attenuates Pulmonary Hypertension in Experimental Congenital Diaphragmatic HerniaCirculation, 2011